Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NBY | US
-0.01
-1.38%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.62
0.63
0.67
0.61
NovaBay Pharmaceuticals Inc. a biopharmaceutical company develops and sells eyecare skincare and wound care products in the United States and internationally. It offers Avenova Spray a solution for removing foreign materials including microorganisms and debris from skin around the eye such as the eyelid; and wound care products which are used for cleansing and irrigation as part of surgical procedures as well as treating certain wounds burns ulcers and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris rosacea and eczema anti-aging hyperhidrosis excessive hair and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors as well as online. The company was formerly known as NovaCal Pharmaceuticals Inc. and changed its name to NovaBay Pharmaceuticals Inc. in February 2007. NovaBay Pharmaceuticals Inc. was incorporated in 2000 and is headquartered in Emeryville California.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
47.6%1 month
50.4%3 months
181.0%6 months
4531.4%-
-
0.29
-3.26
0.51
-0.34
0.30
-
-5.03M
3.03M
3.03M
-
-43.88
-
-32.10
-282.96
0.06
9.25
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.15
Range1M
0.24
Range3M
1.90
Rel. volume
0.51
Price X volume
138.88K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
22nd Century Group Inc | XXII | Biotechnology | 0.105 | 3.30M | 0.10% | n/a | -1072.15% |
Aptevo Therapeutics Inc | APVO | Biotechnology | 0.2389 | 3.21M | 20.35% | n/a | 112.59% |
Galera Therapeutics Inc | GRTX | Biotechnology | 0.0555 | 3.07M | 2.78% | n/a | -0.87% |
Hiru Corporation | HIRU | Biotechnology | 0.0016 | 3.02M | -15.79% | n/a | 263.27% |
SciSparc Ltd. Ordinary Shares | SPRC | Biotechnology | 0.29 | 3.00M | 26.53% | n/a | 1.00% |
Ensysce Biosciences Inc | ENSC | Biotechnology | 0.206 | 2.86M | 15.86% | n/a | 24.79% |
Cyclacel Pharmaceuticals Inc | CYCC | Biotechnology | 1.32 | 2.84M | 15.79% | n/a | 0.50% |
Phio Pharmaceuticals Corp | PHIO | Biotechnology | 3.18 | 2.74M | 9.28% | n/a | 0.00% |
Salarius Pharmaceuticals Inc | SLRX | Biotechnology | 1.82 | 2.62M | -9.45% | n/a | 0.00% |
ZVSA | ZVSA | Biotechnology | 2.3 | 2.47M | 0.00% | 0.00 | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.34 | 0.53 | Cheaper |
Ent. to Revenue | 0.30 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 0.29 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 180.97 | 72.80 | Riskier |
Debt to Equity | -3.26 | -1.23 | Cheaper |
Debt to Assets | 0.51 | 0.25 | Expensive |
Market Cap | 3.03M | 3.66B | Emerging |